[Table/Fig-3]:

Weight, BMI and WHR changes among the study subjects

Parameters	Baseline (Mean ± SD)	4 weeks (Mean ± SD)	8 weeks (Mean ± SD)	Repeated measure ANOVA; p value
Weight (in KG)	Group I (Amisulpride)	52.37±8.41	55.10±8.85	56.71±8.86	<0.0001*
	Group II (Blonanserin)	51.10±9.93	52.87±9.13	54.56±8.72	<0.0001*
	Comparison of weight change in group I with group II by using repeated measure 2-way ANOVA; p-value = 0.461
BMI (Body Mass Index)	Group I (Amisulpride	19.96±2.59	20.99±2.72	21.62±2.76	<0.0001*
	Group II (Blonanserin)	19.37±3.36	20.06±3.14	20.71±3.09	<0.0001*
	Comparison of BMI change in group I with group II by using repeated measure 2-way ANOVA; p-value = 0.334
WHR (Waist Hip Ratio)	Group I (Amisulpride)	0.856±0.058	0.873±0.056	0.892±0.058	<0.0001*
	Group II (Blonanserin)	0.859±0.068	0.874±0.062	0.888±0.059	<0.0001*
	Comparison of WHR change during the study period (8 weeks) in group I with group II by using repeated measure 2-way ANOVA; p-value = 0.994